Innovative CAR-T cell therapy receives FDA Breakthrough Therapy designation (IMAGE)

WashU Medicine

Innovative CAR-T cell therapy receives FDA Breakthrough Therapy designation

Caption

An innovative cell-based immunotherapy developed by WashU Medicine researchers has received Breakthrough Therapy designation from the FDA. The novel CAR-T cell therapy is licensed to Wugen, a WashU Medicine startup based in the Cortex Innovation District in St. Louis (shown).

Credit

Alise O’Brien Photography

Usage Restrictions

Credit: Alise O’Brien Photography

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.